Antiplatelet actions of trimetoquinol isomers: evidence for inhibition of a prostaglandin-independent pathway of platelet aggregation.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000001:Calcimycin / Q000494:pharmacology; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000502:physiology*; D013237:Stereoisomerism; D013917:Thrombin / Q000494:pharmacology; D014213:Tretoquinol / Q000494:pharmacology*; D010738:Type C Phospholipases / Q000494:pharmacology
D000318:Adrenergic beta-Agonists; D007546:Isoquinolines; D011453:Prostaglandins; D000001:Calcimycin; C024531:1-(2',4',5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline; D010738:Type C Phospholipases; D013917:Thrombin; D014213:Tretoquinol